Tag: Launches
-
Glenmark Pharma launches digital inhaler for asthma patients – Times of India
Times of India Glenmark Pharma launches digital inhaler for asthma patientsTimes of IndiaGlenmark Pharmaceuticals Limited, the research-led global integrated pharmaceutical company, launched what the company touted as India's first Digital Dose Inhaler for asthma and pulmonary disease patients. The inhaler, branded as Digihaler, provides …Glenmark launches digital dose inhaler for asthma patientsMoneycontrol.comGlenmark's new 'digital dose inhaler' […]
-
Glenmark launches digital dose inhaler for asthma patients – Moneycontrol.com
Moneycontrol.com Glenmark launches digital dose inhaler for asthma patientsMoneycontrol.com"This next-gen inhaler provides accurate digital dose counter along with low dose warning indicator to enable Asthma and chronic obstructive pulmonary disease (COPD) patients to track adherence to their therapy," the Mumbai-based firm said in a statement.and more » View full post on asthma – Google News
-
Glenmark launches electronic inhaler for asthma patients – Hindu Business Line
Hindu Business Line Glenmark launches electronic inhaler for asthma patientsHindu Business Line"In the case of asthma and COPD condition, where daily preventative medication is crucial for its treatment, implication of non-adherence leads to poor control symptoms, worsening the quality of life, high mortality rate which further increases health …Glenmark launches digital dose inhaler for asthma […]
-
Glenmark launches digital dose inhaler for asthma patients – Financial Express
Financial Express Glenmark launches digital dose inhaler for asthma patientsFinancial Express“This next-gen inhaler provides accurate digital dose counter along with low dose warning indicator to enable Asthma and chronic obstructive pulmonary disease (COPD) patients to track adherence to their therapy,” the Mumbai-based firm said in a statement.Glenmark launches electronic inhaler for asthma patientsHindu Business LineGlenmark […]
-
Glenmark launches digital dose inhaler for asthma patients – Business Standard
Hindu Business Line Glenmark launches digital dose inhaler for asthma patientsBusiness Standard"This next-gen inhaler provides accurate digital dose counter along with low dose warning indicator to enable Asthma and chronic obstructive pulmonary disease (COPD) patients to track adherence to their therapy," the Mumbai-based firm said in a statement.Glenmark launches electronic inhaler for asthma patientsHindu Business […]
-
Sun Pharma launches mobile app for asthma patients – Financial Express
ETCIO.com Sun Pharma launches mobile app for asthma patientsFinancial ExpressAs part of its focus to give boost to treatment compliance amongst Asthma patients by minimising instances of non-adherence and drop-outs in Asthma treatment regime, Sun Pharma Sun Pharma is rolling out India's first unique and innovative mobile …Sun Pharma's RespiTrack mobile app to boost treatment compliance […]
-
Wellapets rebrands to Wizdy, launches asthma app for kids, raises $300K – MobiHealthNews
MobiHealthNews Wellapets rebrands to Wizdy, launches asthma app for kids, raises $300KMobiHealthNewsBoston-based Lifeguard Games, a kid-focused health education game company that did business as Wellapets, has changed its name to Wizdy and launched its first app, called Wizdy Pets, which teaches children about asthma management. Wizdy also … View full post on asthma – Google News
-
Ajanta Pharma launches generic asthma treatment tablets in US – Economic Times
Ajanta Pharma launches generic asthma treatment tablets in USEconomic TimesNEW DELHI: Ajanta Pharma has launched its generic Montelukast Sodium tablets used for treatment of asthma and seasonal allergies in the American market. Ajanta Pharma USA Inc, a subsidiary of the company today announced the launch of Montelukast …Ajanta Pharma launches generic asthma treatment tabletsMoneycontrol.comAjanta Pharma launches […]
-
Ajanta Pharma launches generic asthma drug in US market – ETHealthWorld.com
ETHealthWorld.com Ajanta Pharma launches generic asthma drug in US marketETHealthWorld.comNew Delhi, Nov 16 : Ajanta Pharma today said it has launched generic version of Singulair granules, used in the treatment of asthma, in the US market. The company in a filing to BSE said Ajanta Pharma US Inc has launched montelucast sodium granules, …Ajanta Pharma launches […]
-
Ajanta Pharma Launches Generic Asthma Drug in US Market – NDTV
Ajanta Pharma Launches Generic Asthma Drug in US MarketNDTVNew Delhi: Ajanta Pharma on Monday said it has launched generic version of Singulair granules, used in the treatment of asthma, in the US market. The company in a filing to BSE said Ajanta Pharma US Inc has launched montelucast sodium granules, …and more » View full post on […]